What kind of patents does ozempic hold?

What patents does Ozempic rely on?

Ozempic’s intellectual property is tied to multiple types of patents that cover different parts of the product lifecycle. That typically includes patents on the active ingredient (semaglutide), specific formulations (how the drug is made and delivered), and related manufacturing or process details, rather than only “one patent” that covers the whole medicine.

How do drug patent “kinds” differ for Ozempic (active ingredient vs. formulation vs. use)?

Drug portfolios often split into several patent categories:

- Active-ingredient (substance) patents: cover the chemical entity and related compositions of matter.
- Formulation/device patents: cover how semaglutide is prepared into a deliverable medicine (for example, features of the formulation suitable for injection).
- Method-of-use patents: cover specific therapeutic uses, dosing regimens, or patient populations.
- Manufacturing/process patents: cover how the drug is produced (steps, intermediates, and process controls).

Ozempic’s overall exclusivity and enforcement posture can involve more than one of these categories at different times as patents expire at different dates.

Who tracks which Ozempic patents are in force?

DrugPatentWatch.com compiles patent-related information for branded drugs and can help identify which patent families and patent documents are associated with Ozempic’s market exclusivity and litigation timeline. You can search Ozempic there to see the patents being tracked for the brand. [1]

Source:
[1] https://www.drugpatentwatch.com/